LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma

SIMPLE SUMMARY: Pancreatic adenocarcinoma (PAAD) is a highly malignant tumor with a poor prognosis and lack of effective biomarkers. We demonstrated, using bioinformatics analyses, that the leucine-rich repeat-containing 8A (LRRC8A) can affect the prognosis of patients with PAAD. In addition, experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Rong, Hu, Yaohua, Xie, Qinghua, Zhang, Caiqin, Zhao, Yong, Zhang, He, Shi, Hailong, Wang, Xiaoming, Shi, Changhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688930/
https://www.ncbi.nlm.nih.gov/pubmed/36428619
http://dx.doi.org/10.3390/cancers14225526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688930/
https://www.ncbi.nlm.nih.gov/pubmed/36428619
http://dx.doi.org/10.3390/cancers14225526

Ejemplares similares